Related Experiment Video
Updated: Aug 7, 2026
04:22
Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
Androgens, aging, and Alzheimer's disease
Christian J Pike1, Emily R Rosario, Thuy-Vi V Nguyen
1Andrus Gerontology Center, University of Southern California, Los Angeles, CA 90089-0191, USA. cjpike@usc.edu
Endocrine
|June 21, 2006
Summary
Testosterone depletion in aging men may increase Alzheimer's disease risk. Testosterone influences beta-amyloid and offers neuroprotection, suggesting potential androgen therapies for AD prevention and treatment.
Area of Science:
- Neuroendocrinology
- Neurodegenerative Diseases
- Aging Research
Background:
- Testosterone depletion is a common aging effect in men, impacting androgen-sensitive tissues.
- Senescence and its effects on the body are increasingly studied in relation to age-related diseases.
Purpose of the Study:
- To explore the link between testosterone depletion and an increased risk of Alzheimer's disease (AD).
- To discuss potential mechanisms through which testosterone influences AD pathogenesis.
Main Methods:
- Review of current evidence on testosterone's role in AD.
- Analysis of testosterone's interaction with beta-amyloid.
- Evaluation of testosterone's neurotrophic and neuroprotective properties.
Main Results:
- Testosterone depletion in aging men is associated with a higher risk of developing Alzheimer's disease.
- Testosterone regulates beta-amyloid, a key protein implicated in AD.
- Testosterone exhibits neurotrophic and neuroprotective functions.
Conclusions:
- Testosterone plays a significant role in brain health and AD pathogenesis.
- Androgen-based therapies show promise for preventing and treating Alzheimer's disease.
- Further clinical evaluation of testosterone therapies for AD is warranted.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...